| Spartan Family Dentistry | |
|
5 W Dawes Ave Bixby OK 74008-4422 | |
| (918) 366-3777 | |
| Not Available |
| Full Name | Spartan Family Dentistry |
|---|---|
| Speciality | Dentist |
| Location | 5 W Dawes Ave, Bixby, Oklahoma |
| Authorized Official Name and Position | Martin Trockel (DOCTOR) |
| Authorized Official Contact | 9183663777 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Spartan Family Dentistry 5 W Dawes Ave Bixby OK 74008 Ph: (918) 366-3777 | Spartan Family Dentistry 5 W Dawes Ave Bixby OK 74008-4422 Ph: (918) 366-3777 |
| NPI Number | 1750839163 |
|---|---|
| Provider Enumeration Date | 09/14/2016 |
| Last Update Date | 09/14/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750839163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 6717 (Oklahoma) | Primary |
News Archive
Psychiatry researchers at Washington University School of Medicine in St. Louis have found that a clinical diagnosis of alcohol dependence in young adults is associated with having a high number of sex partners.
A new study out of the Netherlands and published on the preprint server bioRxiv* in July 2020 discusses the commonly observed phenomenon of COVID-19 progression at 1-2 weeks from the onset of the earliest symptoms. This is ascribed to the overactivation of the inflammatory signaling cascade triggered by a hyperactive adaptive immune reaction, commonly called the cytokine storm.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.
Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment or prophylaxis of serious human diseases such as cancer or infectious and autoimmune diseases, today announced that an exclusive worldwide license agreement was signed with Merck KGaA, Darmstadt, Germany, for Sym004, an investigational antibody mixture targeting the epidermal growth factor receptor (EGFR).
› Verified 5 days ago
Innovations Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 14617 S Memorial Dr, Bixby, OK 74008 Phone: 918-366-9500 | |
Advantage Dental Group, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 11907 S Memorial Dr Ste B, Bixby, OK 74008 Phone: 918-394-0303 | |
Dental Care Of Bixby Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12106 S Memorial Dr, Bixby, OK 74008 Phone: 918-364-7000 | |
True Smile Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12345 S Memorial Dr Ste 113, Bixby, OK 74008 Phone: 918-364-2222 | |
Advantage Dental Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 11907 S Memorial Dr Ste B, Bixby, OK 74008 Phone: 918-394-0303 | |
Bixby Dentist, P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 14617 S Memorial Dr, Bixby, OK 74008 Phone: 918-366-9500 | |
Spring Dental Bixby Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12345 S Memorial Dr Ste 103, Bixby, OK 74008 Phone: 918-998-0996 |